[1]
2026. Design, Molecular Docking, and Pharmacokinetic Evaluation of Naproxen-Based 2‑Azetidinone Derivatives for Cancer Treatment. Al Mustansiriyah Journal of Pharmaceutical Sciences. 26, 1 (Mar. 2026), 22–37. DOI:https://doi.org/10.32947/ajps.v26i1.1344.